TEVA ILACLAR SAN VE TIC A.S.

Company Introduction:

TEVA ILACLAR SAN VE TIC A.S. is the Turkish subsidiary of Teva Pharmaceutical Industries Ltd., a global leader in generic and specialty pharmaceuticals. The company operates in Turkey, focusing on the manufacturing, development, and distribution of a wide range of pharmaceutical products. These include generic medicines, specialty pharmaceuticals, and over-the-counter drugs, serving the healthcare needs of the Turkish market.

Nature of Business:

It is primarily a manufacturing facility (factory). While it also engages in the trade and distribution of its pharmaceutical products, its core business involves the industrial production of medicines.

TEVA ILACLAR SAN VE TIC A.S. in Turkey manufactures and sells a wide range of pharmaceutical products, primarily focusing on generic medicines, but also including specialty pharmaceuticals and over-the-counter (OTC) products. Their product portfolio spans various therapeutic areas, addressing a broad spectrum of medical conditions.

Key therapeutic areas and product categories include:

Central Nervous System (CNS) disorders, such as treatments for multiple sclerosis, migraine, Parkinson's disease, and other neurological conditions.

Oncology, providing medications for various types of cancer.

Respiratory diseases, including treatments for asthma and chronic obstructive pulmonary disease (COPD).

Pain management and inflammation.

Cardiovascular diseases.

Women's health.

Infectious diseases.

Dermatology.

Urology.

Gastroenterology.

Metabolic disorders.

As a major generic pharmaceutical company, a significant portion of their offerings consists of generic versions of branded drugs, making essential medicines more accessible. They also market some specialty brand-name products developed by Teva globally.